Tumor Targeted Technology
Enabling the destruction of tumor vasculature.
Built around gold nanoparticles, the Zahav platform is designed to allow cancer therapies to more efficiently target the tumor.
By treating solid tumors in previously impossible-to-dose drug combinations we aim to activate an immune response and disrupt the vasculature of the tumor.
Formulation
Our oncology-specific formulations are engineered to target and disrupt tumor vasculature, cutting off the blood supply tumors rely on. By focusing on the tumor microenvironment, we aim to enhance treatment effectiveness while minimizing harm to healthy tissue. Our approach leverages cutting-edge research to deliver therapies with improved safety profiles for patients. We are committed to advancing cancer treatment through precision design and innovative formulation strategies. Ultimately, our goal is to transform outcomes for patients by making cancer therapies more targeted, efficient, and tolerable.
Innovating on the Platform
Advancements in our formulations are further refining the balance between potency and safety while maximizing drug delivery.
By leveraging these innovations, the platform continues to push the boundaries of nanotechnology-based cancer therapy, potentially enhancing the effectiveness of combination therapy across a variety of tumor types.
